Driving Innovation, Investing in the Future

With over a decade of global experience in managerial and business development roles, Yaron has worked across industries including medical devices, pharmaceuticals, semiconductors, and foodtech. He specializes in guiding products from R&D through international collaborations and successful commercialization across diverse markets.

Yaron lives by the motto: “We don’t stop playing because we grow old; we grow old because we stop playing” (George Bernard Shaw), later echoed by LEGO CEO Jørgen Vig Knudstorp. He believes this mindset applies equally to business—where value and technology spark engagement, but trust, creativity, and play sustain it. For Yaron, even the most complex challenges are best solved when creativity and enjoyment are part of the process.

Outside of work, Yaron is an avid (amateur) beach volleyball player and podcast host. He also helps lead a Tel Aviv-based group that organizes bi-monthly events, where speakers share personal stories of failure, fostering a culture of learning and resilience.

This blend of professional expertise and personal passions shapes Yaron’s unique perspective on both business and life.

—

Coltac Therapeutics is a biotech startup, backed by aMoon and IBF, dedicated to developing the next generation of molecular glues for targeted protein degradation.

The company is advancing three programs: two high-value oncology targets and one non-oncology, leveraging molecular glue hits discovered through its proprietary BOND+ platform.

BOND+ platform combines virtual screening with high-throughput, positive-signal bacterial validation, enabling a rapid and efficient transition to chemical optimization and mammalian cell testing.

—